Bovine campylobacteriosis
Bovine Campylobacteriosis is a bacterial infection affecting cattle, caused by the bacteria Campylobacter fetus. This disease is of significant concern in the livestock industry due to its impact on reproductive efficiency, causing infertility, early embryonic death, and abortion in cows. The condition is zoonotic, meaning it can be transmitted from animals to humans, posing a risk to those in close contact with infected cattle or consuming contaminated products.
Etiology[edit]
Bovine campylobacteriosis is primarily caused by two species of bacteria: Campylobacter fetus subsp. fetus' and Campylobacter jejuni. These bacteria are spiral-shaped, motile, and microaerophilic, thriving in low oxygen environments. Transmission occurs through the oral-fecal route, with the bacteria being shed in the feces of infected animals and contaminating the environment, feed, and water. The disease can also be sexually transmitted through infected semen during artificial insemination.
Clinical Signs[edit]
The clinical manifestations of bovine campylobacteriosis are more pronounced in females, with infected cows experiencing infertility, repeat breeding, and abortions, usually in the last trimester of pregnancy. Bulls, while typically asymptomatic carriers, play a crucial role in the disease's spread through sexual contact and contaminated semen.
Diagnosis[edit]
Diagnosis of bovine campylobacteriosis involves a combination of clinical signs, history, and laboratory tests. Bacteriological culture of preputial or vaginal washes, aborted fetal tissues, and placenta can confirm the presence of Campylobacter. Polymerase Chain Reaction (PCR) assays offer a more rapid, sensitive, and specific method for detecting Campylobacter DNA in clinical samples.
Treatment and Control[edit]
Treatment of bovine campylobacteriosis primarily involves the administration of antibiotics, such as erythromycin, tetracycline, or aminoglycosides, to infected animals. Control measures include improving farm hygiene, implementing strict biosecurity protocols, and regular screening and culling of infected animals. Vaccination of cattle against Campylobacter is also an effective strategy to reduce the incidence of the disease.
Prevention[edit]
Preventive measures focus on minimizing the risk of infection and transmission. These include: - Quarantine and testing of new or returning animals before introducing them to the herd. - Regular veterinary health checks and vaccination of cattle. - Use of pathogen-free semen for artificial insemination. - Maintaining clean water sources and feed to prevent fecal contamination. - Implementing effective rodent and pest control programs to reduce the risk of disease spread.
Public Health Concerns[edit]
Bovine campylobacteriosis poses a public health risk due to the zoonotic potential of Campylobacter. Humans can contract campylobacteriosis through the consumption of contaminated meat, milk, and water or through direct contact with infected animals. In humans, the disease manifests as gastrointestinal illness, characterized by diarrhea, abdominal pain, fever, and sometimes complications such as Guillain-Barré syndrome.
Conclusion[edit]
Bovine campylobacteriosis is a significant disease affecting cattle, with implications for animal health, farm productivity, and public health. Effective management, control, and prevention strategies are essential to mitigate the impact of this disease on the livestock industry and reduce the risk of zoonotic transmission to humans.
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian